DV Biomed Co., Ltd. (TPEX:6539)

Market Cap	1.43B
Revenue (ttm)	712.61M
Net Income (ttm)	52.39M
Shares Out	24.35M
EPS (ttm)	2.04
PE Ratio	28.56
Forward PE	n/a
Dividend	2.37 (4.03%)
Ex-Dividend Date	n/a

Volume	76
Average Volume	8,312
Open	57.70
Previous Close	58.90
Day's Range	57.70 - 58.90
52-Week Range	47.63 - 73.81
Beta	0.11
RSI	55.75
Earnings Date	Mar 27, 2026

About DV Biomed

DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skin care; and beauty products and services. The company was founded in 2011 and is based in Taipei, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Employees: 326
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6539

Financial Performance

In 2024, DV Biomed's revenue was 573.57 million, a decrease of -7.32% compared to the previous year's 618.85 million. Earnings were 89.08 million, a decrease of -45.32%.